Hyperoxidation: influence of various oxygen supply levels on oxidation kinetics of phenolic compounds and wine quality

Chenin blanc, Mauzac and Chardonnay musts were hyperoxidized using three different oxygen levels fixed according to the maximum oxygen consumption capacity determined for each must. Phenolic composition of the control and oxidized musts and that of the corresponding wines were analyzed by HPLC. The wines were also submitted to sensory evaluation. Hyperoxidation hardly modified phenolic composition of Chenin blanc and Mauzac musts which were in fact almost totally oxidized after pressing. As well, it induced no change in wine quality in these two varieties. In Chardonnay musts, concentrations of caffeoyl and p-coumaroyl tartaric acid, 2-S-glutathionyl caffeoyl tartaric acid and catechin decreased with increasing oxygen supplies. Wines contained larger amounts of phenolic compounds than musts because part of the quinones formed during oxidation were reduced when sulfiting, especially for intemediate oxygen levels. Thus, sulfiting should be omitted or delayed to allow quinone condensation and maximum efficency of the hyperoxidation technique. Hyperoxidized Chardonnay wines were rated higher in quality and lower in color than the control

ARTICLE Photon-assisted tunnelling with nonclassical light

International audienceAmong the most exciting recent advances in the field of superconducting quantum circuits is the ability to coherently couple microwave photons in low-loss cavities to quantum electronic conductors. These hybrid quantum systems hold great promise for quantum information-processing applications; even more strikingly, they enable exploration of new physical regimes. Here we study theoretically the new physics emerging when a quantum electronic conductor is exposed to nonclassical microwaves (for example, squeezed states, Fock states). We study this interplay in the experimentally relevant situation where a superconducting microwave cavity is coupled to a conductor in the tunnelling regime. We find that the conductor acts as a nontrivial probe of the microwave state: the emission and absorption of photons by the conductor is characterized by a nonpositive definite quasi-probability distribution, which is related to the Glauber-Sudarshan P-function of quantum optics. These negative quasi-probabilities have a direct influence on the conductance of the conductor

Des possibilités d'emploi du sperme de taureau transporté de France pour l'insémination artificielle dans les territoires d'Outre-mer

Aucun résumé disponible

Phase 2 Study of Dabrafenib Plus Trametinib in Patients With BRAF V600E-Mutant Metastatic NSCLC:Updated 5-Year Survival Rates and Genomic Analysis

Introduction: Dabrafenib plus trametinib was found to have robust antitumor activity in patients with BRAF V600E-mutant metastatic NSCLC (mNSCLC). We report updated survival analysis of a phase 2 study (NCT01336634) with a minimum of 5-year follow-up and updated genomic data. Methods: Pretreated (cohort B) and treatment-naive (cohort C) patients with BRAF V600E-mutant mNSCLC received dabrafenib 150 mg twice daily and trametinib 2 mg once daily. The primary end point was investigator-assessed overall response rate per Response Evaluation Criteria in Solid Tumors version 1.1. Secondary end points were duration of response, progression-free survival, overall survival, and safety. Results: At data cutoff, for cohorts B (57 patients) and C (36 patients), the median follow-up was 16.6 (range: 0.5–78.5) and 16.3 (range: 0.4–80) months, overall response rate (95% confidence interval [CI]) was 68.4% (54.8–80.1) and 63.9% (46.2–79.2), median progression-free survival (95% CI) was 10.2 (6.9–16.7) and 10.8 (7.0–14.5) months, and median overall survival (95% CI) was 18.2 (14.3–28.6) and 17.3 (12.3–40.2) months, respectively. The 4- and 5-year survival rates were 26% and 19% in pretreated patients and 34% and 22% in treatment-naive patients, respectively. A total of 17 patients (18%) were still alive. The most frequent adverse event was pyrexia (56%). Exploratory genomic analysis indicated that the presence of coexisting genomic alterations might influence clinical outcomes in these patients; however, these results require further investigation. Conclusions: Dabrafenib plus trametinib therapy was found to have substantial and durable clinical benefit, with a manageable safety profile, in patients with BRAF V600E-mutant mNSCLC, regardless of previous treatment

A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb–IV non-small-cell lung cancer who failed first-line treatment

Response rate and toxicity of second-line therapy with docetaxel (75 mg m−2) or docetaxel, irinotecan, and lenogastrim (60 mg m−2, 200 mg m−2, and 150 μg m−2 day−1, respectively) were compared in 108 patients with stage IIIb–IV non-small-cell lung cancer. Addition of irinotecan to docetaxel does not improve response rate, and increases gastrointestinal toxicity

Management of emerging multidrug-resistant tuberculosis in a low-prevalence setting

AbstractMultidrug-resistant (MDR) tuberculosis (TB) is an emerging concern in communities with a low TB prevalence and a high standard of public health. Twenty-three consecutive adult MDR TB patients who were treated at our institution between 2007 and 2013 were reviewed for demographic characteristics and anti-TB treatment management, which included surgical procedures and long-term patient follow-up. This report of our experience emphasizes the need for an individualized approach as MDR TB brings mycobacterial disease management to a higher level of expertise, and for a balance to be found between international current guidelines and patient-tailored treatment strategies

Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)

SCOPUS: ar.jinfo:eu-repo/semantics/publishe